- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.70 Å
- Oligo State
- hetero-1-1-1-1-1-1-1-1-1-1-1-1-1-mer
- Ligands
- 4 x PGV: (1R)-2-{[{[(2S)-2,3-DIHYDROXYPROPYL]OXY}(HYDROXY)PHOSPHORYL]OXY}-1-[(PALMITOYLOXY)METHYL]ETHYL (11E)-OCTADEC-11-ENOATE(Non-covalent)
- 2 x HEA: HEME-A(Non-covalent)
HEA.2: 35 residues within 4Å:- Chain A: A.24, G.27, T.31, S.34, I.37, R.38, Y.54, V.58, H.61, A.62, M.65, I.66, M.69, V.70, G.125, W.126, Y.371, F.377, H.378, L.381, S.382, V.386, I.389, F.393, M.417, T.424, F.425, Q.428, R.438, R.439, Y.440, S.458, V.465, M.468
- Ligands: TGL.93
34 PLIP interactions:34 interactions with chain A,- Hydrophobic interactions: A:T.31, A:V.58, A:V.58, A:A.62, A:M.65, A:I.66, A:V.70, A:F.377, A:L.381, A:L.381, A:I.389, A:F.393, A:F.393, A:T.424, A:F.425, A:F.425
- Hydrogen bonds: A:R.38, A:Y.54, A:W.126, A:Y.371, A:S.382, A:Q.428, A:R.439, A:Y.440
- Water bridges: A:R.438, A:R.438, A:S.461
- Salt bridges: A:R.438, A:R.439
- pi-Stacking: A:H.61, A:F.377, A:F.425
- Metal complexes: A:H.61, A:H.378
HEA.3: 33 residues within 4Å:- Chain A: W.126, W.236, V.243, Y.244, I.247, H.290, H.291, T.309, I.312, A.313, T.316, G.317, V.320, T.349, G.352, L.353, G.355, I.356, L.358, A.359, D.364, H.368, V.373, H.376, F.377, V.380, L.381, R.438
- Chain B: I.34, P.69, I.72, L.73
- Ligands: CMO.7
36 PLIP interactions:31 interactions with chain A, 5 interactions with chain B,- Hydrophobic interactions: A:W.236, A:V.243, A:V.243, A:V.243, A:I.247, A:I.247, A:T.309, A:A.313, A:T.316, A:V.320, A:L.353, A:I.356, A:I.356, A:L.358, A:V.373, A:F.377, A:F.377, A:V.380, A:L.381, A:L.381, B:I.34, B:I.34, B:P.69, B:I.72, B:L.73
- Hydrogen bonds: A:W.126, A:Y.244
- Water bridges: A:T.316, A:D.369, A:D.369, A:R.439
- Salt bridges: A:H.368, A:R.438, A:R.439
- pi-Cation interactions: A:H.240
- Metal complexes: A:H.376
- 1 x CU: COPPER (II) ION(Non-covalent)
- 1 x MG: MAGNESIUM ION(Non-covalent)
- 2 x NA: SODIUM ION(Non-functional Binders)
- 1 x CMO: CARBON MONOXIDE(Non-functional Binders)
- 3 x TGL: TRISTEAROYLGLYCEROL(Non-covalent)
TGL.8: 18 residues within 4Å:- Chain A: F.346, V.350, Y.379, F.418, N.422, F.426, H.429, F.430, L.433
- Chain B: L.7, G.8, H.24, L.28, V.31, F.32, S.35, L.39
- Chain I: R.43
20 PLIP interactions:12 interactions with chain A, 7 interactions with chain B, 1 interactions with chain I- Hydrophobic interactions: A:F.346, A:F.346, A:V.350, A:Y.379, A:F.418, A:F.426, A:F.426, A:F.426, A:H.429, A:F.430, A:F.430, A:F.430, B:L.7, B:V.31, B:F.32, B:F.32
- Water bridges: B:G.8, B:F.9
- Salt bridges: B:H.24, I:R.43
TGL.62: 19 residues within 4Å:- Chain A: W.334, M.339, L.342, G.343, F.414, A.415, V.419
- Chain B: L.39, I.42, L.46, T.47, T.48, K.49
- Chain D: R.73, T.75, E.77, W.78, V.81
- Chain I: R.16
16 PLIP interactions:4 interactions with chain B, 5 interactions with chain D, 7 interactions with chain A- Hydrophobic interactions: B:L.39, B:L.46, B:T.47, B:K.49, D:E.77, D:W.78, D:V.81, A:W.334, A:W.334, A:L.342, A:F.414, A:F.414, A:V.419
- Hydrogen bonds: D:E.77, D:W.78
- Salt bridges: A:K.411
TGL.93: 25 residues within 4Å:- Chain A: F.2, T.17, L.18, L.20, L.21, F.22, W.25, F.109, L.110, L.113, F.393, F.400, I.472
- Chain L: I.11, P.12, F.13, S.14, R.20, M.24, L.27, F.28, F.29, S.31
- Ligands: HEA.2, EDO.16
22 PLIP interactions:12 interactions with chain A, 10 interactions with chain L- Hydrophobic interactions: A:T.17, A:L.20, A:L.21, A:W.25, A:W.25, A:W.25, A:F.109, A:F.109, A:F.393, A:F.393, A:F.400, A:I.472, L:I.11, L:F.13, L:F.13, L:F.13, L:L.27, L:F.28, L:F.28, L:F.28, L:F.29, L:F.29
- 64 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)
EDO.10: 6 residues within 4Å:- Chain A: H.256, T.259, K.265, T.490, N.491
- Ligands: EDO.71
Ligand excluded by PLIPEDO.11: 6 residues within 4Å:- Chain A: K.265, T.489
- Chain F: I.70, P.83, S.84
- Ligands: EDO.68
Ligand excluded by PLIPEDO.12: 7 residues within 4Å:- Chain A: Y.19, N.80, N.98, S.101, G.160, N.163, F.164
Ligand excluded by PLIPEDO.13: 8 residues within 4Å:- Chain A: Y.260, Y.261, V.394, H.395, P.398, V.485, W.494
- Chain M: I.1
Ligand excluded by PLIPEDO.14: 9 residues within 4Å:- Chain A: L.483, T.484, V.485, T.488, W.494, G.497, C.498
- Chain D: Y.11
- Ligands: EDO.64
Ligand excluded by PLIPEDO.15: 3 residues within 4Å:- Chain A: M.423
- Chain D: I.89
- Chain K: W.29
Ligand excluded by PLIPEDO.16: 1 residues within 4Å:- Ligands: TGL.93
Ligand excluded by PLIPEDO.17: 4 residues within 4Å:- Chain A: H.503, E.506
- Chain L: H.2
- Ligands: EDO.57
Ligand excluded by PLIPEDO.18: 7 residues within 4Å:- Chain A: H.503, T.504, F.505, E.506, E.507
- Ligands: EDO.57, EDO.77
Ligand excluded by PLIPEDO.19: 8 residues within 4Å:- Chain A: N.406, E.474, S.478, R.480
- Chain M: P.9, T.10, Q.15
- Ligands: PGV.1
Ligand excluded by PLIPEDO.20: 5 residues within 4Å:- Chain A: L.136, A.137
- Chain B: Q.103, W.104
- Ligands: EDO.21
Ligand excluded by PLIPEDO.21: 6 residues within 4Å:- Chain A: Q.52, A.120, A.137, H.138, A.139
- Ligands: EDO.20
Ligand excluded by PLIPEDO.22: 2 residues within 4Å:- Chain A: P.131, D.221
Ligand excluded by PLIPEDO.23: 5 residues within 4Å:- Chain A: I.229, H.233
- Chain B: R.178
- Ligands: CHD.38, PGV.44
Ligand excluded by PLIPEDO.24: 7 residues within 4Å:- Chain A: G.269, Y.270, M.271, G.272
- Chain B: A.58, Q.59, E.62
Ligand excluded by PLIPEDO.25: 8 residues within 4Å:- Chain A: K.265, E.266
- Chain B: T.55
- Chain F: N.66, T.68, I.70, S.84
- Ligands: EDO.75
Ligand excluded by PLIPEDO.26: 5 residues within 4Å:- Chain A: I.286, W.288, Y.304
- Ligands: CHD.38, PGV.44
Ligand excluded by PLIPEDO.27: 4 residues within 4Å:- Chain A: C.498
- Chain D: S.8, Y.11
- Chain L: P.7
Ligand excluded by PLIPEDO.28: 6 residues within 4Å:- Chain A: E.507
- Chain C: T.5
- Chain F: P.30, N.32, P.50
- Ligands: EDO.76
Ligand excluded by PLIPEDO.29: 9 residues within 4Å:- Chain A: R.5, N.11, K.13, D.14, W.81, P.499, P.500, Y.502
- Chain L: N.10
Ligand excluded by PLIPEDO.30: 8 residues within 4Å:- Chain A: P.444, D.445, A.446
- Chain B: M.1, A.2, L.133, R.134, L.136
Ligand excluded by PLIPEDO.33: 7 residues within 4Å:- Chain A: Y.447
- Chain B: M.1, A.2, Q.10, L.136, P.166, Y.193
Ligand excluded by PLIPEDO.34: 3 residues within 4Å:- Chain B: T.125, L.135, F.206
Ligand excluded by PLIPEDO.35: 7 residues within 4Å:- Chain B: S.14, P.15, I.16, L.168, T.183, L.184, M.185
Ligand excluded by PLIPEDO.36: 5 residues within 4Å:- Chain A: D.227
- Chain B: G.177, R.178
- Chain H: N.24, T.26
Ligand excluded by PLIPEDO.37: 4 residues within 4Å:- Chain B: T.55, M.56, D.57, A.58
Ligand excluded by PLIPEDO.49: 7 residues within 4Å:- Chain C: W.146, S.150, H.158
- Chain F: A.1
- Chain G: A.13, R.14, R.17
Ligand excluded by PLIPEDO.50: 2 residues within 4Å:- Chain C: F.251, V.254
Ligand excluded by PLIPEDO.51: 6 residues within 4Å:- Chain C: N.12, P.13
- Chain J: G.17, L.18, P.19
- Ligands: EDO.52
Ligand excluded by PLIPEDO.52: 8 residues within 4Å:- Chain C: N.12, Q.68
- Chain J: L.18, V.20, K.23
- Ligands: EDO.51, EDO.53, EDO.92
Ligand excluded by PLIPEDO.53: 6 residues within 4Å:- Chain C: Q.68, H.70
- Chain J: Q.13
- Ligands: EDO.52, EDO.56, EDO.92
Ligand excluded by PLIPEDO.54: 5 residues within 4Å:- Chain A: P.222, A.223
- Chain B: G.177
- Chain C: E.111
- Ligands: EDO.55
Ligand excluded by PLIPEDO.55: 5 residues within 4Å:- Chain B: G.177
- Chain C: E.111
- Chain H: W.68, W.72
- Ligands: EDO.54
Ligand excluded by PLIPEDO.56: 3 residues within 4Å:- Chain C: H.3, H.70
- Ligands: EDO.53
Ligand excluded by PLIPEDO.57: 6 residues within 4Å:- Chain A: E.506
- Chain C: H.3
- Chain F: I.52
- Ligands: EDO.17, EDO.18, EDO.77
Ligand excluded by PLIPEDO.58: 5 residues within 4Å:- Chain C: M.152, E.153, G.154, S.229
- Chain F: T.8
Ligand excluded by PLIPEDO.59: 4 residues within 4Å:- Chain C: T.145, H.148, H.149
- Chain G: W.16
Ligand excluded by PLIPEDO.63: 5 residues within 4Å:- Chain D: K.121, D.125, W.138, N.143
- Chain K: P.50
Ligand excluded by PLIPEDO.64: 9 residues within 4Å:- Chain A: T.484, T.488, L.495
- Chain D: Y.11, L.13, P.14, S.15
- Ligands: EDO.14, EDO.78
Ligand excluded by PLIPEDO.65: 5 residues within 4Å:- Chain E: Y.18, K.21, I.24, E.28
- Ligands: EDO.69
Ligand excluded by PLIPEDO.66: 3 residues within 4Å:- Chain E: R.14, W.15, Y.18
Ligand excluded by PLIPEDO.67: 7 residues within 4Å:- Chain D: Y.22, D.26
- Chain E: W.27, R.30, K.31, N.34
- Chain F: P.83
Ligand excluded by PLIPEDO.68: 4 residues within 4Å:- Chain D: Y.22
- Chain E: T.35
- Chain F: P.83
- Ligands: EDO.11
Ligand excluded by PLIPEDO.69: 3 residues within 4Å:- Chain E: E.28
- Chain F: R.81
- Ligands: EDO.65
Ligand excluded by PLIPEDO.71: 7 residues within 4Å:- Chain A: T.489, T.490
- Chain F: S.67, T.68, V.69, W.71
- Ligands: EDO.10
Ligand excluded by PLIPEDO.72: 6 residues within 4Å:- Chain A: Y.510
- Chain F: P.36, K.37, T.39, N.47, L.48
Ligand excluded by PLIPEDO.73: 4 residues within 4Å:- Chain C: P.73, H.231
- Chain F: D.9, E.17
Ligand excluded by PLIPEDO.74: 3 residues within 4Å:- Chain F: G.3, G.4, G.5
Ligand excluded by PLIPEDO.75: 5 residues within 4Å:- Chain A: E.266
- Chain F: N.66, S.67, T.68
- Ligands: EDO.25
Ligand excluded by PLIPEDO.76: 7 residues within 4Å:- Chain A: Y.510
- Chain F: N.32, P.36, P.50, R.56
- Ligands: EDO.28, EDO.81
Ligand excluded by PLIPEDO.77: 3 residues within 4Å:- Chain F: T.53
- Ligands: EDO.18, EDO.57
Ligand excluded by PLIPEDO.78: 9 residues within 4Å:- Chain A: L.495
- Chain D: Y.11, A.12, L.13, P.14
- Chain F: F.72, W.73
- Ligands: EDO.64, EDO.79
Ligand excluded by PLIPEDO.79: 5 residues within 4Å:- Chain F: F.72, Q.80, R.81, P.83
- Ligands: EDO.78
Ligand excluded by PLIPEDO.80: 6 residues within 4Å:- Chain A: Q.180, L.513, K.514
- Chain F: I.61, E.64, D.65
Ligand excluded by PLIPEDO.81: 9 residues within 4Å:- Chain A: P.174, T.509, Y.510, V.511
- Chain F: N.32, L.34, P.36, R.56
- Ligands: EDO.76
Ligand excluded by PLIPEDO.83: 6 residues within 4Å:- Chain C: G.120
- Chain G: A.46, F.47, I.48, L.53, R.54
Ligand excluded by PLIPEDO.84: 4 residues within 4Å:- Chain G: P.49, Y.50, H.51, P.79
Ligand excluded by PLIPEDO.85: 4 residues within 4Å:- Chain G: I.48, P.49
- Chain H: E.78, G.79
Ligand excluded by PLIPEDO.87: 5 residues within 4Å:- Chain I: Y.54, D.55, K.58, D.59, E.62
Ligand excluded by PLIPEDO.90: 2 residues within 4Å:- Chain J: K.10, Q.13
Ligand excluded by PLIPEDO.91: 1 residues within 4Å:- Ligands: EDO.92
Ligand excluded by PLIPEDO.92: 7 residues within 4Å:- Chain J: Q.13, E.14, D.15, K.23
- Ligands: EDO.52, EDO.53, EDO.91
Ligand excluded by PLIPEDO.94: 2 residues within 4Å:- Chain L: F.38
- Ligands: CHD.96
Ligand excluded by PLIPEDO.95: 2 residues within 4Å:- Chain L: H.2, Y.3
Ligand excluded by PLIP- 1 x PSC: (7R,17E,20E)-4-HYDROXY-N,N,N-TRIMETHYL-9-OXO-7-[(PALMITOYLOXY)METHYL]-3,5,8-TRIOXA-4-PHOSPHAHEXACOSA-17,20-DIEN-1-AMINIUM 4-OXIDE(Non-covalent)
PSC.31: 16 residues within 4Å:- Chain A: F.321, L.324, A.325, H.328
- Chain B: L.37, I.41, M.45, H.52, M.56, D.57, E.60, V.61, W.65
- Chain E: D.8
- Chain I: R.10, L.17
13 PLIP interactions:6 interactions with chain B, 2 interactions with chain E, 4 interactions with chain A, 1 interactions with chain I- Hydrophobic interactions: B:L.37, B:I.41, B:I.41, B:W.65, A:F.321, A:F.321, A:L.324, A:A.325, I:L.17
- Hydrogen bonds: B:D.57, B:E.60
- Salt bridges: E:D.8
- pi-Cation interactions: E:F.11
- 1 x CUA: DINUCLEAR COPPER ION(Non-covalent)
- 5 x CHD: CHOLIC ACID(Non-covalent)
CHD.38: 11 residues within 4Å:- Chain A: H.233, W.288, D.300, T.301, Y.304, F.305
- Chain C: W.99, H.103
- Ligands: EDO.23, EDO.26, PGV.44
10 PLIP interactions:7 interactions with chain A, 3 interactions with chain C- Hydrophobic interactions: A:W.288, A:Y.304, A:F.305, C:W.99
- Hydrogen bonds: A:T.301, C:W.99
- Water bridges: A:D.300, A:T.301
- Salt bridges: A:H.233, C:H.103
CHD.47: 5 residues within 4Å:- Chain C: W.116, P.117, W.258, W.259, S.261
3 PLIP interactions:3 interactions with chain C- Water bridges: C:S.261, C:S.261, C:S.261
CHD.48: 7 residues within 4Å:- Chain C: R.156, L.160, Q.161, F.164, F.219, L.223
- Chain J: F.1
9 PLIP interactions:7 interactions with chain C, 2 interactions with chain J- Hydrophobic interactions: C:L.160, C:F.164, C:F.164, C:F.164, C:F.219, C:L.223, J:F.1
- Salt bridges: C:R.156
- Hydrogen bonds: J:F.1
CHD.89: 8 residues within 4Å:- Chain A: I.3, L.7, F.8
- Chain J: Y.32, R.33, M.36, T.37, L.40
6 PLIP interactions:5 interactions with chain J, 1 interactions with chain A- Hydrophobic interactions: J:R.33, A:I.3
- Hydrogen bonds: J:Y.32, J:Y.32, J:R.33, J:R.33
CHD.96: 10 residues within 4Å:- Chain A: L.113, M.117
- Chain J: F.55
- Chain L: A.35, F.38, I.39, R.41, H.42, L.45
- Ligands: EDO.94
4 PLIP interactions:3 interactions with chain L, 1 interactions with chain J- Hydrophobic interactions: L:L.45, J:F.55
- Hydrogen bonds: L:R.41, L:R.41
- 3 x PEK: (1S)-2-{[(2-AMINOETHOXY)(HYDROXY)PHOSPHORYL]OXY}-1-[(STEAROYLOXY)METHYL]ETHYL (5E,8E,11E,14E)-ICOSA-5,8,11,14-TETRAENOATE(Non-covalent)
PEK.40: 13 residues within 4Å:- Chain A: V.193
- Chain C: K.77, R.80, Y.81, I.84, L.85, V.91, T.95, F.98, W.240, F.244, V.247, F.251
16 PLIP interactions:14 interactions with chain C, 2 interactions with chain A- Hydrophobic interactions: C:Y.81, C:I.84, C:L.85, C:V.91, C:F.98, C:F.98, C:W.240, C:W.240, C:F.244, C:V.247, A:V.193, A:V.193
- Hydrogen bonds: C:K.77, C:Y.81, C:Y.81
- Salt bridges: C:K.77
PEK.41: 28 residues within 4Å:- Chain A: H.151, V.155, A.203, T.207, L.210, L.215
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.70 Å
- Oligo State
- hetero-1-1-1-1-1-1-1-1-1-1-1-1-1-mer
- Ligands
- 4 x PGV: (1R)-2-{[{[(2S)-2,3-DIHYDROXYPROPYL]OXY}(HYDROXY)PHOSPHORYL]OXY}-1-[(PALMITOYLOXY)METHYL]ETHYL (11E)-OCTADEC-11-ENOATE(Non-covalent)
- 2 x HEA: HEME-A(Non-covalent)
- 1 x CU: COPPER (II) ION(Non-covalent)
- 1 x MG: MAGNESIUM ION(Non-covalent)
- 2 x NA: SODIUM ION(Non-functional Binders)
- 1 x CMO: CARBON MONOXIDE(Non-functional Binders)
- 3 x TGL: TRISTEAROYLGLYCEROL(Non-covalent)
- 64 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)
- 1 x PSC: (7R,17E,20E)-4-HYDROXY-N,N,N-TRIMETHYL-9-OXO-7-[(PALMITOYLOXY)METHYL]-3,5,8-TRIOXA-4-PHOSPHAHEXACOSA-17,20-DIEN-1-AMINIUM 4-OXIDE(Non-covalent)
- 1 x CUA: DINUCLEAR COPPER ION(Non-covalent)
- 5 x CHD: CHOLIC ACID(Non-covalent)
- 3 x PEK: (1S)-2-{[(2-AMINOETHOXY)(HYDROXY)PHOSPHORYL]OXY}-1-[(STEAROYLOXY)METHYL]ETHYL (5E,8E,11E,14E)-ICOSA-5,8,11,14-TETRAENOATE(Non-covalent)